EGFR Mutation Positive Non-small Cell Lung Cancer
4 clinical trials · Condition
◉ Watch EGFR Mutation Positive Non-small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer (NCT07315113) | Nuvectis Pharma, Inc. | 2025-12-18 |
| First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy (NCT02906163) | SciClone Pharmaceuticals | 2016-10-01 |
| Genetics of EGFR (Epidermal Growth Factor Receptor) Mutation Study (NCT01838577) | European Organisation for Research and Treatment of Cancer - EORTC | 2013-09-01 |
| Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis (NCT01776684) | Samsung Medical Center | 2012-06-01 |
Track EGFR Mutation Positive Non-small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.